Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RUBIN, S. H.
Right arrow Articles by RITTER, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RUBIN, S. H.
Right arrow Articles by RITTER, E. D.
(Chest. 1952;21:439-449.)
© 1952 American College of Chest Physicians

Determination of Blood Plasma Levels of Hydrazine Derivatives of Isonicotinic Acid

SAUL H. RUBIN Ph.D.; LEON DREKTER ; JACOB SCHEINER M.S.; and ELMER DE RITTER B.S.1

1 Hoffmann-La Roche, Inc., Nutley, New Jersey.

A colorimetric method is presented for the determination of blood plasma levels of isonicotinic acid and its derivatives, the hydrazide (Rimifon) and the isopropyl hydrazide (Marsilid). The method is based on the reaction of isonicotinic acid with cyanogen bromide and ammonia. The hydrazide derivatives, which yield relatively slight color per se, are converted to isonicotinic acid by treatment of the protein-free plasma with permanganate. Plasma levels over a 24-hour period after a single oral dose are presented for dogs given 3.5, 7 or 14 mg. per kilogram of Rimifon or Marsilid and for humans receiving up to 3.4 mg. of Rimifon or 3.2 mg. of Marsilid per kilogram. In these limited trials maximum plasma levels are usually found within one-half to two hours after dose and decline rapidly. No significant amount of either compound was found in the plasma after 24 hours.

Submitted on January 19, 1952







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1952 by the American College of Chest Physicians.